Glucagon shortage — BE supply status & alternatives

Glucagon

—

🇦🇺 AUST R 47105 · Novo Nordisk Pharmaceuticals Pty Ltd

In supply · Australia

Baqsimi

In supply · 🇦🇺 Australia · short in🇩🇪 DE🇫🇷 FR🇧🇪 BE

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$35.01DPMQ A$50.88details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Glucagon

Brand names	Baqsimi

Therapeutic category	Auto-created by Agence nationale de sécurité du médicament — Disponibilité scraper

Controlled substance	No

Marketing-authorisation holders	Novo Nordisk Pharmaceuticals Pty Ltd, Mylan Pharmaceuticals Inc., Professional Complementary Health Formulas, FRESENIUS KABI USA, LLC +2 more

Registrations on file	6

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$35.01

AEMP

Dispensed (DPMQ)

A$50.88

incl. fees

Pack

glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack

Source: PBSEffective July 2026 · AUD

Other markets

🇺🇸 US

US$165.09

Acquisition

🇪🇸 ES

€21.46

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

3 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

High concentration risk

Bachem AGAmbiopharm INCFresenius Kabi Ipsum Srl

Manufacturing countries: Switzerland, United States, Italy · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders6 registrations · 6 MA holders

Product	Strength	Form	Market	MA holder	Status
GLUCAGEN HYPOKIT glucagon	1mg	—	🇦🇺 AU	Novo Nordisk Pharmaceuticals Pty Ltd	Active
Glucagon	—	kit	🇺🇸 US	Mylan Pharmaceuticals Inc.	Active
Glucagon	9[hp_X]/29.5mL	liquid	🇺🇸 US	Professional Complementary Health Formulas	Active
Glucagon	1mg/mL	injection	🇺🇸 US	FRESENIUS KABI USA, LLC	Active
Glucagon Ampoule 666	1MG	solution	🇨🇦 CA	ELI LILLY AND COMPANY LIMITED	Active
GLUCAGON	—	solution	🇨🇦 CA	ELI LILLY CANADA INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.